Skip to content

8-KAccepted Oct 22, 7:15 AM ET

Sagimet Biosciences Inc.: regulation fd disclosure

SGMTSagimet Biosciences Inc.

Accepted (ET)

7:15 AM

Oct 22, 2026

Filed

Oct 22, 2026

Documents

43

Size

4.3 MB

Summary

Sagimet Biosciences Inc.: regulation fd disclosure

Updated

What happened Sagimet Biosciences Inc announced on Oct 22, 2026 that it updated information reflected in a slide presentation, which is attached as Exhibit 99.1 to the Current Report on Form 8-K and is incorporated by reference. The filing states that representatives of the company will use the updated presentation in various meetings with investors from time to time.

Key details

  • The item reported is Item 7.01: Regulation FD Disclosure, dated Oct 22, 2026.
  • The updated investor slide presentation is attached as Exhibit 99.1 to the Form 8-K.
  • Company representatives will use the updated presentation in various investor meetings from time to time.

Why it may matter The filing reports Item 7.01 (Regulation FD Disclosure), which covers updated information the company is making available to investors via a slide presentation. This filing does not show why the insider traded or why the company acted.

AI-written summary · check the filing